Inherited mutations in genes involved in DNA repair processes (BRCA1, BRCA2), cell cycle checkpoints and apoptosis (p53, Rb), and gene products that regulate critical pathways (PTEN) clearly play a central role in predetermining the initiation of cancers, often with an incomplete penetrance. The gene discussed is BRCA2; the disease is cancer.